NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
07/18/2025
Back to search
Official data from USPTO
ADAPTIVE CLINICAL SYSTEMS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
08/12/2025
Trademark type
Combined
Nice classes
35, 42
Filing date
06/24/2014
Registration date
03/31/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/18/2025
Last transaction
08/12/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
2012-05-00
First use in commerce
2012-05-00
Drawing code
3
Owner type
16
Owner location
Venice, FL
Examiner
BLANE, SUZANNE
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the words "ADAPTIVE CLINICAL SYSTEMS", with a design element between the words "ADAPTIVE" and "CLINICAL" where the design element has a vertical line between two outwardly directed arcs, and with the word "SYSTEMS" below the word "CLINICAL".
Holders and representatives
Holders
Adaptive Clinical LLC
Adaptive Clinical LLC
Representatives
Steven D. Lustig PANITCH SCHWARZE BELISARIO & NADEL LLP
Technical classification
Nice Classes
Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
business consulting and management in the field of clinical trials and medical researchproviding information management servicesmanagement and compilation of computerized databases in the field of clinical trials and medical research for business purposes
Class 42
application service provider (ASP) featuring software for use in clinical trial database management; application service provider (ASP) hostingmanagingdevelopinganalyzingmaintaining applicationssoftware and websites of others in the fields of clinical trials and medical research
Publications
History of USPTO decisions and trademark events.
30 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
07/18/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
07/18/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/18/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
02/19/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/31/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
05/03/2021
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05/03/2021
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
04/30/2021
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
03/15/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/15/2021
E815
TEAS SECTION 8 & 15 RECEIVED
12/07/2020
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/31/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
03/31/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/13/2015
PUBO
PUBLISHED FOR OPPOSITION
01/13/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/24/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/05/2014
ALIE
ASSIGNED TO LIE
12/04/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/17/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/22/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/22/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/22/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/15/2014
GNRT
NON-FINAL ACTION E-MAILED
10/15/2014
CNRT
NON-FINAL ACTION WRITTEN
10/15/2014
DOCK
ASSIGNED TO EXAMINER
09/30/2014
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/02/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/01/2014
NWAP
NEW APPLICATION ENTERED
06/27/2014
Continuous trademark protection
Get notified about every new filing that threatens ADAPTIVE CLINICAL SYSTEMS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.